Lifeboat Foundation

Popular spit-in-a-tube genetics-testing companies like Ancestry and 23andMe can — and frequently do — sell your data to drugmakers. But on Wednesday, one of those partnerships became much more explicit, when the pharmaceutical giant GlaxoSmithKline announced it was acquiring a $300 million stake in 23andMe.

As part of a four-year deal between the two companies, GlaxoSmithKline will comb 23andMe’s genetic data to look for new drugs to develop, also referred to as drug targets. It will also use the genetic data to inform how patients are selected for clinical trials.

If that news has you thinking about how your own genetic material is being used for research, know that though the DNA you submit to these services is ostensibly anonymized, leaks can happen, and privacy advocates say that such incidents could allow your data to find its way elsewhere, perhaps without your knowledge.

Continue reading “DNA-testing company 23andMe has signed a $300 million deal with a drug giant. Here’s how to delete your data if that freaks you out” »

What’s the longest you’ve ever slept?

Building on several years of research into a protein responsible for leukemia, a newly published paper has revealed success in slowing the progression of the deadly cancer in mouse models. The researchers suggest two new prospective therapies can now be combined into one “super drug” and progress into human clinical trials.

We can barely believe our eyes – this solar power plant floats in a man-made lake… over what was once a filthy coal mine. (via World Economic Forum)

The most detailed simulation of the universe shows how galaxies evolved since the dawn of time.

This machine lets you recycle plastic at home 😲
Credit: http://bit.ly/2mzzFKz

Amazing bicycle reaches speeds above 85MPH using only human power.

• Scientists at the University of Brisbane may have found a simple way of detecting the early stages of cancer.
• The method is inexpensive, takes 10 minutes, and can work for all types of cancer.
• The test uses gold particles to detect cancerous DNA.

According to Nature, researchers at the University of Brisbane may have developed a simple test that’s able to detect the early stages of cancer.

Not only that but the method is inexpensive, takes a mere 10 minutes, and works for all types of cancer — and the central component used for identifying cancer cells is gold particles.

Seneca Valley virus sounds like the last bug you’d want to catch, but it could be the next breakthrough cancer therapy. Now, scientists at the Okinawa Institute of Science and Technology (OIST) and the University of Otago have described exactly how the virus interacts with tumors—and why it leaves healthy tissues alone.

The study, published in the Proceedings of the National Academy of Sciences on October 29, 2018, provides the first detailed images of how the complex Seneca Valley virus forms with its preferred receptor. The researchers used cryo-electron microscopy to capture images of over 7000 particles and rendered the structure in high resolution. They predict their results will help scientists develop the virus, and other viral drug candidates, for clinical use.

“If you have a virus that targets cancer cells and nothing else, that’s the ultimate cancer fighting tool,” said Prof. Matthias Wolf, principal investigator of the Molecular Cryo-Electron Microscopy Unit at OIST and co-senior author of the study. “I expect this study will lead to efforts to design viruses for cancer therapy.”

Continue reading “Anti-cancer virus fits tumor receptor like a ‘key in a lock’” »